NCT06350838 2024-04-05
Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)
Chengdu CoenBiotech Co., Ltd
Phase 1 Completed